BioSpace News Archive

Demands for antibodies have risen strikingly for a range of research and diagnostic applications. Particularly, the demand for custom antibodies for drug development and diagnostics has grown steadily over the past few decades.

According to the report, the global depth of anesthesia monitoring devices market was valued at ~US$ 256 Mn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030.

Avacta Group plc, the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that the MHRA has confirmed registration of Avacta’s AffiDX® SARS-CoV-2 antigen lateral flow test allowing the Company to place the product on the market in the UK for professional use.

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and ClexBio, a pioneer in solutions for tissue engineering and single-cell techniques, announced the launch of the biocompatible CYTRIX Microfluidic Hydrogel Kit.

Cergentis and collaborators publish a method for accurate and automatic detection of clinically relevant translocations in tumor biopsies

Renalytix AI plc announced a series of key hires to drive its commercialization strategy in the United States market in light of the recently announced Federal Government General Service Administration payment contract and additional large healthcare system partnerships.

Equipment transfer positions Prodigy to expedite production expansion and next-generation disease-resistant silkworms

Microbot Medical Inc. continues its ongoing commitment to strengthen and broaden its capabilities as Giora Weisz, MD joined the Company’s Scientific Advisory Board.

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), today announced the article, “Safety and tolerability of lumateperone: a pooled analysis of late-phase placebo-and active-controlled clinical trials” (Kane et al. 2021), was recently published online in International Clinical Psychopharmacology

Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), today announced the appointment of Neha Krishnamohan as Chief Financial Officer and Executive Vice President